CSF biomarkers for Parkinson's disease: loss of glucocerebrosidase activity and alterations in modified forms of alpha-synuclein

被引：0
|
作者：
Gramsbergen, J. B. [1 ]
Andersen, A. D. [1 ,2 ,3 ]
Iversen, P. L. [4 ]
Blaabjerg, M. [5 ]
Binzer, M. [3 ]
Pakkenberg, B. [4 ]
Brudek, T. [4 ]
Heegaard, N. H. H. [6 ]
Stenager, E. [2 ,3 ]
机构：
[1] Univ Southern Denmark, Inst Mol Med, Odense, Denmark
[2] Hosp Southern Jutland, Focused Res Grp Neurol, Aabenraa, Denmark
[3] Univ Southern Denmark, Inst Reg Hlth Res, Aabenraa, Denmark
[4] Bispebjerg Frederiksberg Hosp, Res Lab Stereol & Neurosci, Copenhagen, Denmark
[5] Zealand Univ Hosp, Dept Neurol, Roskilde, Denmark
[6] Statens Serum Inst, Dept Autoimmunol Biomarkers, Copenhagen, Denmark
来源：
JOURNAL OF NEUROCHEMISTRY | 2017年 / 142卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
MTU04-09
引用
收藏
页码：108 / 109
页数：2
相关论文
共 50 条
  • [1] Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance
    Blanz, Judith
    Saftig, Paul
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 198 - 215
  • [2] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
    Majbour, Nour K.
    Vaikath, Nishant N.
    van Dijk, Karin D.
    Ardah, Mustafa T.
    Varghese, Shiji
    Vesterager, Louise B.
    Montezinho, Liliana P.
    Poole, Stephen
    Safieh-Garabedian, Bared
    Tokuda, Takahiko
    Teunissen, Charlotte E.
    Berendse, Henk W.
    van de Berg, Wilma D. J.
    El-Agnaf, Omar M. A.
    MOLECULAR NEURODEGENERATION, 2016, 11
  • [3] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Nour K. Majbour
    Nishant N. Vaikath
    Karin D. van Dijk
    Mustafa T. Ardah
    Shiji Varghese
    Louise B. Vesterager
    Liliana P. Montezinho
    Stephen Poole
    Bared Safieh-Garabedian
    Takahiko Tokuda
    Charlotte E. Teunissen
    Henk W. Berendse
    Wilma D. J. van de Berg
    Omar M. A. El-Agnaf
    Molecular Neurodegeneration, 11
  • [4] Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease
    Majbour, N. K.
    Vaikath, N. N.
    Dijk, K. D.
    Ardah, M.
    Teunissen, C. E.
    Berendse, H. W.
    Berg, W. D. J.
    El-Agnaf, O. M. A.
    MOVEMENT DISORDERS, 2016, 31 : S630 - S630
  • [5] Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles
    Lerche, Stefanie
    Wurster, Isabel
    Roeben, Benjamin
    Zimmermann, Milan
    Riebenbauer, Benjamin
    Deuschle, Christian
    Hauser, Ann-Kathrin
    Schulte, Claudia
    Berg, Daniela
    Maetzler, Walter
    Waniek, Katharina
    Lachmann, Ingolf
    Liepelt-Scarfone, Inga
    Gasser, Thomas
    Brockmann, Kathrin
    MOVEMENT DISORDERS, 2020, 35 (03) : 495 - 499
  • [6] Oligomeric alpha-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
    Emelyanov, A. K.
    Baydakova, G. V.
    Andoskin, P. A.
    Nikolaev, M. A.
    Senkevich, K. A.
    Milyukhina, I. V.
    Yakimovskii, A. F.
    Timofeeva, A. A.
    Fedotova, E. Y.
    Nuzhnyi, E. P.
    Illarioshkin, S. N.
    Zakharova, E. Y.
    Pchelina, S. N.
    MOVEMENT DISORDERS, 2016, 31 : S214 - S215
  • [7] Salivary biomarkers in Parkinson's disease: alpha-synuclein and beyond
    Vivacqua, G.
    De Bartolo, M.
    Belvisi, D.
    Mancinelli, R.
    Fabbrini, G.
    Berardelli, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 720 - 721
  • [8] Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
    Li, Puyu
    Xu, Pingyi
    Liu, Jun
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
  • [9] Alpha-synuclein and Parkinson's disease
    Golbe, LI
    MOVEMENT DISORDERS, 1999, 14 (01) : 6 - 9
  • [10] Alpha-synuclein and Parkinson's disease
    Lücking, CB
    Brice, A
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (13-14) : 1894 - 1908
12345